Report Highlights
The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.
Report Includes
- 21 data tables and 26 additional tables
- An up-to-date overview and industry analysis of the global markets for minimally invasive medical surgical devices and instruments within the industry
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the current market size and revenue growth forecast for the global minimally invasive medical devices market in USD million values, and corresponding market share analysis based on equipment type, application, end user, and region
- Identification of the segments of main types of minimally invasive devices and instruments that have been commercialized till date
- Analysis of historical and current volume and value of shipments of each of these product segments in specified end user and geographic markets
- Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market in the coming years (2023-2028)
- Identification of promising new surgical procedures and products still in the development and testing stage and assess their probability of successful commercialization in the next 5 years
- A look at the leading device manufacturers and analyze the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration and recent merger and acquisition (M&A) activity)
- Discussion of the current state of minimally invasive medical surgical devices and instruments, commercialized and pipeline products, regulations and standards, as well as key industry aspects
- Review of the key patent grants and patent applications on minimally invasive medical surgical devices and instruments
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading global players of the industry, including 3M, Abbott, Danaher Corp., Johnson & Johnson and Olympus Corp.
Report Scope
This report on minimally invasive medical devices is segmented based on equipment types, application types and end users.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. A Porter’s Five Forces analysis and the supply and distribution chain are discussed in detail for an in-depth market understanding. The report covers the current regulations and guidelines for minimally invasive medical devices. The report includes top market players detailing their business operations, segment focus, revenue, and strategy analysis. Market share analysis of leading market players, product launches, and pipeline products are also captured in the information.
Regarding geography, the reports analyze the market across North America, Europe, and Asia-Pacific. Key countries like the U.S., Canada, Mexico, Europe (top five countries), China, India, and Japan are discussed due to the high concentration of minimally invasive medical device manufacturing companies and contract manufacturing organizations in these countries.
The base year for market data is 2022, with historical data for 2020 and forecast data for 2028. Historical, base year and forecast data are provided for each market segment of the report.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||
| Base year market size | $26.4 billion | ||||||||||||||||
| Market size forecast | $41.0 billion | ||||||||||||||||
| Growth rate | CAGR of 7.6% | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | equipment type, application, and end user | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (ROW) | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- B Braun
- Johnson & Johnson
- Novartis
- Stryker
- Medtronic
Analyst Credentials
Kalyani Kottapenta – Assistant Manager, Life Sciences
Kalyani Kottapenta is a research professional with nine years of experience in the life sciences and healthcare industry. Her expertise in qualitative and quantitative market information, including market dynamics like market sizing, advanced excel based market modeling, data analysis, forecasting, company share analysis, and competitive landscape assessment of the medical device industry, developing custom reports. She holds a master’s degree in Microbiology and a bachelor’s in Biotechnology and Chemistry.
Report Highlights
The global market for MIS devices and equipment sales should grow from $21.2 billion in 2019 to $29.9 billion by 2024 with a compound annual growth rate (CAGR) of 7.1% for the period of 2019-2024.
Report Includes
- 38 tables
- An overview of the global markets for minimally invasive medical devices
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Regional dynamics of the market covering Americas, EMRA, APAC and other emerging economies
- Discussion of current state of minimally invasive surgical devices and equipments, commercialized and pipeline products, regulations and legislations, as well as key industry aspects
- Examination of vendor landscape and profiles of industry leading players, including B. Braun Aesculap, Fujifim Holdings Corp., Medtronic Ent Inc., Stryker Corp., Olympus Optical Co., Ltd. and Gyrus Acmi Corp.
Report Highlights
The global market for MIS devices and equipment was about $14.5 billion in 2013. This market reached about $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a compound annual growth rate (CAGR) of 6.8% for the period 2014-2019.
Report Includes
- An overview of the global markets for minimally invasive medical devices and instruments.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Historical and current volume and value data for shipments, specified by end user and geographic markets.
- Evaluation of demographic, economic, and other factors that will drive future demand for minimally invasive devices.
- Details concerning promising new surgical procedures and products still in the development and testing stage, and assessments of the probability that they will be commercialized successfully in the next five years.
- Analysis of the potential market for these developmental procedures and products, taking into account the estimated probability that they will be commercialized.
- A look at the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration, and recent M&A activity).
Report Highlights
The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010. The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.
Report Highlights
- The global market for MIS devices and instruments was worth $14.8 billion in 2008. This should reach $15.8 billion in 2009 and $23.0 billion in 2014, for a compound annual growth rate (CAGR) of 7.8%.
- The U.S. has the largest share of the market, worth $8.9 billion in 2008 and an estimated $9.5 billion in 2009. This segment is expected to reach $13.6 billion in 2014.
- Cardiothoracic surgery was the largest application segment for MIS devices and equipment in 2007, representing 70% of the total market. Cardiothoracic surgery was followed in order of size by orthopedic surgery (12%), gastrointestinal surgery (10%) and gynecology (3%).
Report Highlights
-
The global market for minimally invasive surgery (MIS) devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011, an average annual growth rate (AAGR) of 7.5% between 2006 and 2011. (These figures include catheters, balloons, stents and other devices used in minimally invasive angioplasty.)
-
The U.S. accounted for about 60% of the world market, or $7.2 billion in 2005, and is growing at an AAGR of 7.2%. The U.S. market should reach $7.7 billion in 2006 and $11.0 billion by 2011.
-
Surgical devices (e.g, stents, catheters, guidewires) are the largest product segment of the U.S. minimally invasive surgery market, of which they accounted for about a 69% share in 2005. Monitoring and visualization systems were the second largest segment of the U.S. market in 2005, with an 11% market share, followed by endosurgical instruments (10%), electrosurgical equipment (8%), and robotics (2%). Surgical robots are the fastest-growing equipment /device segment, with an AAGR of 12% between 2006 and 2011, followed by surgical devices, with an AAGR of 8%.
Report Highlights
-
Globally, the MIS devices market saw an average annual growth rate (AAGR) of 10% from 1999 to 2002.
-
By 2007, the market should rise to approximately $8.3 billion at an AAGR of 6.6%.
-
The U.S. market represents nearly 60% of the total world market.
-
Market drivers include demographics, epidemiology, new devices.
-
The lack of surgeons opting to train in MIS is a potential constraint on the market.
Related Reports
Medical Robotics and Computer-assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
The Market for Minimally Invasive Medical Devices
The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More